查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999392

抗凝血滅鼠劑市場：按類型、配方、作用機制、目標囓齒動物、應用方法和最終用戶分類－2026-2032年全球市場預測

Anticoagulant Rodenticides Market by Type, Formulation, Mode Of Action, Target Rodent, Application Method, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，抗凝血滅鼠劑市場價值將達到 11.5 億美元，到 2026 年將成長到 12.9 億美元，到 2032 年將達到 29.6 億美元，複合年成長率為 14.41%。

主要市場統計數據
基準年 2025 11.5億美元
預計年份：2026年 12.9億美元
預測年份 2032 29.6億美元
複合年成長率 (%) 14.41%

簡明扼要地介紹影響抗凝血滅鼠劑市場趨勢的關鍵挑戰、監管壓力和科學複雜性，供相關人員。

目前抗凝血滅鼠劑的現狀是化學、生態學、監管和商業性需求之間錯綜複雜的相互作用。從製劑生產商和農民到市政害蟲防治計畫和住宅服務供應商，相關人員都必須應對不斷變化的關於滅鼠劑有效性和抗藥性的科學認知、日益成長的環境管理期望，以及日益嚴格的法規，這些法規強調保護非目標生物和上市後監測。

深刻洞察正在重新定義產品開發、韌性動態、環境政策以及整個價值鏈中相關人員期望的變革性變化。

抗凝血滅鼠劑目前正經歷一場變革，這場變革是由科技、監管和市場主導因素共同推動的。分子毒理學和監測技術的進步提高了檢測亞致死效應和二次暴露途徑的準確性，迫使監管機構和採購方重新評估可接受的風險閾值。同時，囓齒類抗藥性模式的改變也促使產品開發商重新評估其首選的化學結構以及產品中包含的環境控制措施。

對美國在 2025 年實施的累積關稅措施及其對抗凝血滅鼠劑製造商的營運、供應鏈和合規性影響進行重點分析。

美國於2025年實施的累積關稅措施對製造業、分銷業和分銷服務業的企業產生了立竿見影的連鎖反應。進口成本的增加促使一些經銷商重新評估其供應商多元化策略，並尋求本地採購原料和成品，以降低貿易政策變化帶來的風險。同時，關稅措施也改變了採購節奏，許多買家為了應對政策變化而加快採購，而另一些買家則考慮與多家供應商簽訂合約以分散風險。

以數據為驅動的細分洞察，將類型、配方、作用機制、目標物種、最終用戶和應用方法轉化為決策者的策略重點。

有效的策略細分需要從產品類型入手，並將技術屬性轉化為營運優先事項。第一代抗凝血劑（靶向Chlorophacinone、Coumatetralyl、地法西酮、吡多康和Warfarin）與第二代抗凝血劑（靶向溴地法康、Bromadiolone地隆、地芬那康、Difethialone和氟庫馬芬）相比，其殘留期往往較短，管理模式也不同。第二代抗凝血劑通常需要考慮更高的效力和更長的殘留期。這種差異會影響抗藥性管理、環境暴露以及最終用戶的選擇。

整合美洲、歐洲、中東和非洲以及亞太市場的需求促進因素、管理體制和物流限制的區域資訊。

區域趨勢對監理立場、商業風險和商業策略有顯著影響。在美洲，相關人員所處的司法管轄區必須平衡強勁的農業需求與日益嚴格的環境審查。採購往往優先考慮營運可靠性和成本效益，而監管機構則強調減輕對非目標生物的影響以及事件報告。因此，供應鏈優先考慮快速分銷、本地化技術支援以及符合聯邦和州級要求的管理方案。

對引領抗凝血滅鼠劑產業創新、管理和商業策略的主要企業進行競爭分析和能力評估。

抗凝血滅鼠劑產業的競爭地位取決於活性成分和配方的創新、完善的監管管理計劃、監管專業知識和分銷能力。主要企業正透過持續投資產品管理、透明的環境風險溝通以及與用戶和市政採購負責人建立夥伴關係，在其價值鏈中建立最佳實踐。這種方法可以降低聲譽風險，並支援基於可衡量管理成果的長期合約。

提出可操作且優先考慮的建議，以降低監管風險、最佳化配方、加強管理，並使商業模式與永續性要求保持一致。

行業領導企業應採取一系列優先行動，將監管意識和科學知識轉化為營運韌性和商業性優勢。首先，應建立一個跨職能的管理委員會，協調毒理學、監管回應、供應鏈和銷售等部門，確保在不同司法管轄區內，配方選擇、標籤更新和使用指南保持一致。這種一體化的管治將加快合規速度，並有助於向採購商和監管機構訊息一致的訊息。

我們向相關人員清楚地展示了調查方法、資料來源和分析框架，以確保研究的嚴謹性、可重複性和有助於決策的洞察力。

支持這些發現的研究結合了定性和定量方法，以確保分析的嚴謹性和可重複性。主要方法包括對毒理學、產品開發、法規事務和害蟲防治領域的從業人員進行訪談，以了解實際操作情況和新出現的挑戰。輔助分析整合了同行評審文獻、已發布的法規文件和技術指導文件，以闡明活性成分的行為、抗藥性報告和最佳管理實踐的背景。

一份綜合考慮監管、技術、商業和區域因素的概要報告，旨在指導行業領導者和政策制定者得出可操作的結論。

總之，此綜合分析結合了監管趨勢、技術差異化、供應鏈現狀和區域差異，為整個價值鏈上的領導者提供了針對性的見解。首先，科學進步和抗藥性監測凸顯了持續投資於活性成分管理和應用方法創新的必要性。其次，貿易政策的變化和關稅壓力表明，供應鏈設計和採購的柔軟性已成為一項策略挑戰，直接影響商業性可行性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 抗凝血滅鼠劑市場：按類型分類

  • 第一代
    • Chlorophacinone
    • Coumatetralyl
    • 雙相酮
    • 粉紅唐
    • Warfarin
  • 第二代
    • 布羅迪·法庫姆
    • Bromadiolone
    • 吉芬納庫姆
    • Difethialone
    • Flocoumafen

第9章：抗凝血滅鼠劑的市場分類（按劑型）

  • 堵塞
  • 顆粒狀
  • 液體
  • 貼上
  • 顆粒

第10章：抗凝血滅鼠劑的市場作用機制

  • 香豆素
    • 布羅迪·法庫姆
    • Bromadiolone
    • Coumatetralyl
    • 吉芬納庫姆
    • Difethialone
    • Flocoumafen
    • Warfarin
  • 印度錫安
    • Chlorophacinone
    • 雙相酮
    • 粉紅唐

第11章：抗凝血劑市場中的目標囓齒動物

  • 老鼠
  • 老鼠
  • 松鼠
  • 田鼠

第12章：抗凝血滅鼠劑市場依應用方法分類

  • 飼料箱
  • 在洞穴裡準備食物
  • 液體噴塗
  • 散點圖

第13章 抗凝血滅鼠劑市場：依最終用戶分類

  • 農業
  • 商業的
  • 工業的
  • 地方政府
  • 住宅

第14章 抗凝血滅鼠劑市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 抗凝血滅鼠劑市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 抗凝血滅鼠劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國抗凝血滅鼠劑市場

第18章：中國抗凝血滅鼠劑市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • A. SAJ Agricare Pvt. Ltd
  • Adama Agricultural Solutions Ltd.
  • Anticimex AB
  • Arbuda Agrochemicals Ltd
  • BASF SE
  • Bayer AG
  • De Sangosse Group
  • Ecolab Inc.
  • FMC Corporation
  • Heranba Industries Ltd
  • Impex Europa SL
  • Kalyani Industries Limited
  • Killgerm Group Ltd
  • Motomco Ltd
  • Neogen Corporation
  • Orkin LLC
  • PelGar International PLC
  • POMAIS Agriculture
  • Rollins, Inc.
  • SenesTech, Inc.
  • Sichuan Sunshine Biotech Co., Ltd.
  • Sumitomo Chemical Co., Ltd.
  • Syngenta AG
  • Truly Nolen Group
  • UPL Limited
Product Code: MRR-3A2E844FF1DD

The Anticoagulant Rodenticides Market was valued at USD 1.15 billion in 2025 and is projected to grow to USD 1.29 billion in 2026, with a CAGR of 14.41%, reaching USD 2.96 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.15 billion
Estimated Year [2026] USD 1.29 billion
Forecast Year [2032] USD 2.96 billion
CAGR (%) 14.41%

A concise introduction framing the critical issues, regulatory pressures, and scientific complexities shaping the anticoagulant rodenticide landscape for stakeholders

The anticoagulant rodenticide landscape presents a complex intersection of chemistry, ecology, regulatory scrutiny, and commercial necessity. Stakeholders ranging from formulators and agricultural operators to municipal pest-control programs and residential service providers must navigate evolving scientific evidence on efficacy and resistance, increasing expectations for environmental stewardship, and a tightening regulatory environment that emphasizes non-target protection and post-market monitoring.

Against this backdrop, an effective introduction reframes the conversation: rodenticides are not solely a product category but a system of practices that couples toxicology with application method, species behavior, and supply chain reliability. Recent advances in active ingredient chemistry and formulation technology have altered operational expectations, while parallel developments in application infrastructure-such as bait-station design and tamper-resistant delivery-have shifted the locus of value toward integrated service offerings.

Consequently, decision-makers should approach product selection and program design with an emphasis on compatibility among active ingredient selection, mode of action, target rodent ecology, and end-user needs. This introductory perspective establishes the central premise of the report: durable pest management outcomes derive from aligning technical properties of anticoagulant solutions with regulatory requirements and stakeholder priorities across the value chain.

An incisive review of transformative shifts redefining product development, resistance dynamics, environmental policy, and stakeholder expectations across the value chain

The landscape for anticoagulant rodenticides is undergoing transformative shifts that are simultaneously technical, regulatory, and market-driven. Advances in molecular toxicology and surveillance have sharpened detection of sublethal effects and secondary exposure pathways, prompting regulators and purchasers to reassess acceptable risk thresholds. At the same time, documented changes in rodent resistance patterns have driven product developers to re-evaluate both the chemical scaffolds they prioritize and the stewardship measures they bundle with commercial offerings.

Parallel to these scientific drivers, procurement behavior is evolving. Large agricultural and municipal buyers increasingly demand demonstrable environmental safeguards, evidence of reduced non-target exposure, and supply chain transparency. As a result, suppliers are investing in formulation innovations that enhance palatability and targeted delivery while minimizing environmental persistence. In addition, integration of digital monitoring and bait-station telemetry is reshaping service models toward outcome-based contracts where efficacy metrics and incident reporting are central to commercial relationships.

Taken together, these shifts are creating new competitive dynamics: organizations that can link robust toxicological profiles with responsible application systems and clear regulatory pathways will be better positioned to capture long-term contracts and to lead stewardship initiatives. In this environment, responsiveness to scientific findings and proactive engagement with regulatory frameworks are no longer optional but foundational to commercial resilience.

A focused analysis of cumulative United States tariff measures enacted in 2025 and their operational, supply chain, and compliance consequences for anticoagulant rodenticide operators

The introduction of cumulative tariff measures in the United States during 2025 has had immediate and cascading implications for operators across manufacturing, distribution, and application services. Increased import costs have prompted some distributors to reassess vendor diversification and to seek nearer-sourced ingredients or finished goods to reduce exposure to trade policy volatility. In parallel, tariffs have shifted procurement timing, with many buyers accelerating purchases ahead of policy milestones and others exploring multi-supplier contracts to spread risk.

Operationally, tariffs have emphasized the importance of supply chain visibility and contractual flexibility. Companies with tighter intercompany logistics, domestic manufacturing capabilities, or long-term supplier agreements have experienced fewer disruptions, while those reliant on single-source imports have faced heightened inventory and margin pressures. Additionally, compliance costs associated with classification, documentation, and customs protocols have required closer collaboration between regulatory, procurement, and commercial teams to avoid shipment delays and potential enforcement actions.

From a strategic standpoint, the tariff environment has reinforced the value of scenario planning: sensitivity to input-cost fluctuation, contingency sourcing plans, and revisiting formulation options to allow substitution where regulatory and efficacy considerations permit. Decision-makers now view trade policy as a material factor that affects not only cost structures but also timelines for product launches, registration renewals, and stewardship program rollouts.

Data-driven segmentation insights that translate type, formulation, mode of action, target species, end user, and application method into strategic priorities for decision makers

Effective strategic segmentation requires translating technical attributes into operational priorities, beginning with product type. First Generation anticoagulants-studied across Chlorophacinone, Coumatetralyl, Diphacinone, Pindone, and Warfarin-tend to be associated with shorter persistence and different stewardship profiles compared with Second Generation agents, which are studied across Brodifacoum, Bromadiolone, Difenacoum, Difethialone, and Flocoumafen and often present greater potency and persistence considerations. This dichotomy has implications for resistance management, environmental exposure, and end-user selection.

Formulation choices further refine strategy; formulations studied across Blocks, Grain, Liquid, Paste, and Pellets each carry unique application and palatability characteristics that influence where and how products are deployed. The mode of action categorization clarifies biochemical targeting: Coumarin compounds-further studied across Brodifacoum, Bromadiolone, Coumatetralyl, Difenacoum, Difethialone, Flocoumafen, and Warfarin-contrast with Indanedione agents-further studied across Chlorophacinone, Diphacinone, and Pindone-in terms of metabolic pathways and implications for resistance monitoring.

Target species segmentation across Mice, Rats, Squirrels, and Voles drives both formulation selection and application method, because species-specific foraging and habitat behaviors determine optimal delivery. End-user segmentation across Agricultural, Commercial, Industrial, Municipal, and Residential contexts dictates regulatory exposure, acceptable residual profiles, and stewardship expectations. Finally, application methods studied across Bait Stations, Burrow Baiting, Liquid Baiting, and Loose Bait shape operational protocols and risk management frameworks. Integrating these dimensions yields a segmentation-led framework that supports differentiated product positioning and targeted risk mitigation strategies.

Regional intelligence synthesizing demand drivers, regulatory regimes, and logistical constraints across the Americas, Europe, Middle East & Africa, and the Asia-Pacific markets

Regional dynamics materially influence regulatory posture, operational risk, and commercial strategies. In the Americas, stakeholders operate in jurisdictions that balance robust agricultural demand with growing environmental scrutiny; procurement tends to prioritize operational reliability and cost-effectiveness, while regulators emphasize non-target impact mitigation and incident reporting. Consequently, supply chains emphasize responsive distribution, localized technical support, and stewardship programs that align with both federal and state-level expectations.

Across Europe, Middle East & Africa, regulatory regimes are diverse and often more prescriptive regarding environmental persistence and secondary exposure. This heterogeneity necessitates granular regulatory intelligence and tailored product stewardship measures. In many EMEA jurisdictions, there is heightened emphasis on monitoring and reporting, and manufacturers frequently need to adapt labeling, allowable formulations, and application guidance to meet disparate national standards. Market access here is therefore dependent on regulatory agility and sustained stakeholder engagement.

In the Asia-Pacific region, demand drivers include rapid urbanization, diverse agricultural practices, and an increasing focus on food security that shapes acceptable control practices. Supply chain logistics can vary widely across the region, and commercial players must account for disparate distribution infrastructure and differing enforcement intensity. Across all regions, successful strategies hinge on aligning technical performance with local regulatory expectations and end-user preferences, while maintaining the flexibility to respond to region-specific incident management requirements.

Competitive profiling and capability assessment of leading companies driving innovation, stewardship, and commercial strategy within the anticoagulant rodenticide sector

Competitive positioning within the anticoagulant rodenticide sector is shaped by a combination of innovation in active ingredients and formulations, strength of stewardship programs, regulatory expertise, and distribution capabilities. Leading organizations demonstrate consistent investment in product stewardship, transparent environmental risk communication, and partnerships with applicators and municipal buyers to embed best practices across the value chain. This approach reduces reputational risk and supports longer-term contracts that hinge on measurable stewardship outcomes.

In addition to technical leadership, commercial differentiation often arises from integrated service models. Suppliers that offer bundled solutions-combining optimized formulation with bait-station infrastructure, monitoring services, and training-achieve closer alignment with large institutional buyers who prioritize outcome assurance. Similarly, companies that cultivate rigorous internal compliance teams and proactive regulatory engagement can accelerate registration updates and smoothly navigate label changes required by jurisdictional shifts.

Distribution strategy also matters: firms with diversified logistics, regional warehouses, and strong channels into agricultural cooperatives and municipal procurement tend to maintain higher availability and responsiveness during periods of trade disruption. Ultimately, competitive advantage accrues to organizations that marry scientific credibility with operational excellence, robust stewardship, and the ability to adapt commercial models to evolving regulatory and buyer expectations.

Actionable, prioritized recommendations to mitigate regulatory risk, optimize formulations, strengthen stewardship, and align commercial models with sustainability imperatives

Industry leaders should adopt a set of prioritized actions that translate regulatory awareness and scientific insight into operational resilience and commercial advantage. First, establish cross-functional stewardship committees that link toxicology, regulatory affairs, supply chain, and sales to ensure that formulation choices, labeling updates, and application guidance remain aligned across jurisdictions. This integrated governance reduces time-to-compliance and supports consistent messaging to buyers and regulators.

Second, diversify sourcing and build flexibility into supply contracts to mitigate tariff and trade-policy exposure. Where feasible, invest in regional manufacturing or strategic partnerships that reduce reliance on vulnerable import routes. Third, accelerate adoption of targeted delivery systems and evidence-based application protocols that reduce non-target exposure and support favorable regulatory engagement. Investing in bait-station telemetry and validated monitoring protocols can demonstrate measurable outcomes that appeal to institutional buyers.

Fourth, prioritize transparent communication with regulators and end-users by publishing stewardship data and incident-response procedures. Such transparency builds trust and reduces the likelihood of punitive actions. Finally, align commercial offerings with sustainability objectives by exploring lower-persistence formulations where efficacy and regulatory frameworks permit, and by designing training programs that ensure correct field application across diverse end-user groups. Collectively, these actions create a defensible market position while addressing the environmental and regulatory priorities that increasingly determine procurement decisions.

Clear exposition of the research methodology, data sources, and analytical frameworks used to ensure rigor, reproducibility, and decision-grade insights for stakeholders

The research underpinning these insights combines qualitative and quantitative approaches designed to ensure analytical rigor and reproducibility. Primary methods include interviews with technical experts across toxicology, product development, regulatory affairs, and pest management practitioners to capture operational realities and emergent challenges. Secondary analysis integrates peer-reviewed literature, public regulatory filings, and technical guidance documents to contextualize active-ingredient behavior, resistance reporting, and stewardship best practices.

Analytical frameworks applied in this work include comparative product profiling that maps active ingredient properties to ecological persistence and non-target risk, segmentation analysis linking application method to species behavior, and scenario planning to evaluate supply chain resilience under alternative trade-policy environments. Data validation is achieved through triangulation across multiple sources and targeted expert review to ensure that interpretations reflect current industry practice.

Throughout, emphasis was placed on transparency of assumptions and methodological limitations. Where jurisdictional regulatory detail is summarized, the methodology notes the range of approaches and highlights areas where local consultation is required. These methodological choices support decision-grade insights while acknowledging the need for jurisdiction-specific follow-up in regulatory-sensitive contexts.

A concluding synthesis that connects regulatory, technical, commercial, and regional threads into pragmatic conclusions for industry leaders and policymakers

The concluding synthesis draws together regulatory trends, technical differentiation, supply chain realities, and regional nuance into a focused set of takeaways for leaders across the value chain. First, scientific developments and resistance monitoring underscore the need for ongoing investment in active-ingredient stewardship and application innovation. Second, trade-policy shifts and tariff pressures demonstrate that supply chain design and sourcing flexibility are now strategic imperatives that directly affect commercial viability.

Third, segmentation clarity-across type, formulation, mode of action, target species, end user, and application method-enables more precise product positioning and risk mitigation. Fourth, regional dynamics affirm that granular regulatory intelligence and localized operational models are essential for market access and sustained uptake. Taken together, these threads point toward an industry future where efficacy, environmental stewardship, regulatory engagement, and supply chain resilience are integrated priorities rather than separate initiatives.

Decision-makers should therefore prioritize cross-functional alignment, invest in telemetry and monitoring, and pursue supplier diversification and regional operational capabilities as core strategic pillars. By doing so, organizations can both meet immediate compliance challenges and position themselves for sustained leadership as policy and ecological conditions continue to evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anticoagulant Rodenticides Market, by Type

  • 8.1. First Generation
    • 8.1.1. Chlorophacinone
    • 8.1.2. Coumatetralyl
    • 8.1.3. Diphacinone
    • 8.1.4. Pindone
    • 8.1.5. Warfarin
  • 8.2. Second Generation
    • 8.2.1. Brodifacoum
    • 8.2.2. Bromadiolone
    • 8.2.3. Difenacoum
    • 8.2.4. Difethialone
    • 8.2.5. Flocoumafen

9. Anticoagulant Rodenticides Market, by Formulation

  • 9.1. Blocks
  • 9.2. Grain
  • 9.3. Liquid
  • 9.4. Paste
  • 9.5. Pellets

10. Anticoagulant Rodenticides Market, by Mode Of Action

  • 10.1. Coumarin
    • 10.1.1. Brodifacoum
    • 10.1.2. Bromadiolone
    • 10.1.3. Coumatetralyl
    • 10.1.4. Difenacoum
    • 10.1.5. Difethialone
    • 10.1.6. Flocoumafen
    • 10.1.7. Warfarin
  • 10.2. Indanedione
    • 10.2.1. Chlorophacinone
    • 10.2.2. Diphacinone
    • 10.2.3. Pindone

11. Anticoagulant Rodenticides Market, by Target Rodent

  • 11.1. Mice
  • 11.2. Rats
  • 11.3. Squirrels
  • 11.4. Voles

12. Anticoagulant Rodenticides Market, by Application Method

  • 12.1. Bait Stations
  • 12.2. Burrow Baiting
  • 12.3. Liquid Baiting
  • 12.4. Loose Bait

13. Anticoagulant Rodenticides Market, by End User

  • 13.1. Agricultural
  • 13.2. Commercial
  • 13.3. Industrial
  • 13.4. Municipal
  • 13.5. Residential

14. Anticoagulant Rodenticides Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Anticoagulant Rodenticides Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Anticoagulant Rodenticides Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Anticoagulant Rodenticides Market

18. China Anticoagulant Rodenticides Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. A. SAJ Agricare Pvt. Ltd
  • 19.6. Adama Agricultural Solutions Ltd.
  • 19.7. Anticimex AB
  • 19.8. Arbuda Agrochemicals Ltd
  • 19.9. BASF SE
  • 19.10. Bayer AG
  • 19.11. De Sangosse Group
  • 19.12. Ecolab Inc.
  • 19.13. FMC Corporation
  • 19.14. Heranba Industries Ltd
  • 19.15. Impex Europa S.L.
  • 19.16. Kalyani Industries Limited
  • 19.17. Killgerm Group Ltd
  • 19.18. Motomco Ltd
  • 19.19. Neogen Corporation
  • 19.20. Orkin LLC
  • 19.21. PelGar International PLC
  • 19.22. POMAIS Agriculture
  • 19.23. Rollins, Inc.
  • 19.24. SenesTech, Inc.
  • 19.25. Sichuan Sunshine Biotech Co., Ltd.
  • 19.26. Sumitomo Chemical Co., Ltd.
  • 19.27. Syngenta AG
  • 19.28. Truly Nolen Group
  • 19.29. UPL Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANTICOAGULANT RODENTICIDES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ANTICOAGULANT RODENTICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ANTICOAGULANT RODENTICIDES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 242. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 243. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 244. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 245. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 246. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 248. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 249. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 275. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 276. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 277. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 278. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 279. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 280. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 281. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 282. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 284. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 286. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 287. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 288. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 289. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 290. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 291. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 292. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 293. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 294. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES ANTICOAGULANT RODENTICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA ANTICOAGULANT RODENTICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. CHINA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2032 (USD MILLION)
  • TABLE 309. CHINA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2032 (USD MILLION)
  • TABLE 310. CHINA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 311. CHINA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 312. CHINA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2032 (USD MILLION)
  • TABLE 313. CHINA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2032 (USD MILLION)
  • TABLE 314. CHINA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2032 (USD MILLION)
  • TABLE 315. CHINA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)